Endocrine Abstracts

Early detection is essential for curative cancer therapy and for achieving a decrease in cancer mortality. Markers for incipient stages of every type of cancer constitute therefore all oncologists’ dream. We have recently uncovered a new tumor marker, the FSH receptor (FSHR). Compared with the available markers, FSHR is found in a wide array of cancers, including eleven of the most frequent types. We have shown by various methods that FSHR is expressed in >1300 human ...